Literature DB >> 11327854

A structural variation for MurB: X-ray crystal structure of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (MurB).

T E Benson1, M S Harris, G H Choi, J I Cialdella, J T Herberg, J P Martin, E T Baldwin.   

Abstract

The X-ray crystal structure of the substrate free form of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (MurB) has been solved to 2.3 A resolution with an R-factor of 20.3% and a free R-factor of 22.3%. While the overall fold of the S. aureus enzyme is similar to that of the homologous Escherichia coli MurB X-ray crystal structure, notable distinctions between the S. aureus and E. coli MurB protein structures occur in residues involved in substrate binding. Analysis of available MurB sequences from other bacteria suggest that the S. aureus MurB structure is representative of a distinct structural class of UDP-N-acetylenolpyruvylglucosamine reductases including Bacillus subtilis and Helicobacter pylori that are characterized by a modified mechanism for substrate binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327854     DOI: 10.1021/bi002162d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria.

Authors:  Youjun Yang; Anatoly Severin; Rajiv Chopra; Girija Krishnamurthy; Guy Singh; William Hu; David Keeney; Kristine Svenson; Peter J Petersen; Pornpen Labthavikul; David M Shlaes; Beth A Rasmussen; Amedeo A Failli; Jay S Shumsky; Kristina M K Kutterer; Adam Gilbert; Tarek S Mansour
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Substrate Channel Flexibility in Pseudomonas aeruginosa MurB Accommodates Two Distinct Substrates.

Authors:  Ming Wei Chen; Bernhard Lohkamp; Robert Schnell; Julien Lescar; Gunter Schneider
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

3.  LucY: A Versatile New Fluorescent Reporter Protein.

Authors:  Michele E Auldridge; Hongnan Cao; Saurabh Sen; Laura P Franz; Craig A Bingman; Ragothaman M Yennamalli; George N Phillips; David Mead; Eric J Steinmetz
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

4.  Design, Synthesis and Antibacterial Activity of Coumarin-1,2,3-triazole Hybrids Obtained from Natural Furocoumarin Peucedanin.

Authors:  Alla V Lipeeva; Danila O Zakharov; Liubov G Burova; Tatyana S Frolova; Dmitry S Baev; Ilia V Shirokikh; Alexander N Evstropov; Olga I Sinitsyna; Tatyana G Tolsikova; Elvira E Shults
Journal:  Molecules       Date:  2019-06-05       Impact factor: 4.411

Review 5.  Development of Phenothiazine Hybrids with Potential Medicinal Interest: A Review.

Authors:  Marina C Posso; Fernanda C Domingues; Susana Ferreira; Samuel Silvestre
Journal:  Molecules       Date:  2022-01-03       Impact factor: 4.411

6.  Targeted Isolation of Antibiotic Brominated Alkaloids from the Marine Sponge Pseudoceratina durissima Using Virtual Screening and Molecular Networking.

Authors:  James Lever; Florian Kreuder; Jason Henry; Andrew Hung; Pierre-Marie Allard; Robert Brkljača; Colin Rix; Aya C Taki; Robin B Gasser; Jan Kaslin; Donald Wlodkowic; Jean-Luc Wolfender; Sylvia Urban
Journal:  Mar Drugs       Date:  2022-08-29       Impact factor: 6.085

7.  Thiazolidin-4-Ones as Potential Antimicrobial Agents: Experimental and In Silico Evaluation.

Authors:  Christophe Tratrat; Anthi Petrou; Athina Geronikaki; Marija Ivanov; Marina Kostić; Marina Soković; Ioannis S Vizirianakis; Nikoleta F Theodoroula; Michelyne Haroun
Journal:  Molecules       Date:  2022-03-16       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.